Ayyadevara et al. (2025), Ayyadevara et al., (2022) performed a kinome-wide CRISPR screen and identified DYRK1A as a factor required for KMT2A-R ALL cell survival, but not in other high-risk ALL subtypes. Here, KMT2A is linked to acute lymphoblastic leukemia.